NCT02132572View on ClinicalTrials.gov

Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants

CompletedOBSERVATIONAL
Enrollment

201

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Breast Implantation
Interventions
DEVICE

BIOCELL™ Textured 410 Implant

Previously received a Natrelle BIOCELL™ textured 410 implant for primary breast augmentation.

Trial Locations (5)

Unknown

Bordeaux

Düsseldorf

Tel Aviv

Madrid

East Grinstead

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT02132572 - Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants | Biotech Hunter | Biotech Hunter